Related references
Note: Only part of the references are listed.Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
Christian D. Fankhauser et al.
BRITISH JOURNAL OF CANCER (2022)
MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data
Sharmila Rana et al.
BRITISH JOURNAL OF CANCER (2022)
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
Klaus-Peter Dieckmann et al.
WORLD JOURNAL OF UROLOGY (2022)
MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer
Mette Pernille Myklebust et al.
CANCER GENOMICS & PROTEOMICS (2022)
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Einar Stikbakke et al.
CANCERS (2022)
Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
Klaus-Peter Dieckmann et al.
FRONTIERS IN ONCOLOGY (2022)
DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients
Jose Pedro Sequeira et al.
FRONTIERS IN ONCOLOGY (2022)
Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management
Rohit R. Badia et al.
JOURNAL OF UROLOGY (2021)
High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours
Klaus-Peter Dieckmann et al.
UROLOGIA INTERNATIONALIS (2021)
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
Gazanfer Belge et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Circulating microRNAs as biomarkers to assist the management of the malignant germ-cell-tumour subtype choriocarcinoma
Matthew J. Murray et al.
TRANSLATIONAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
Joao Lobo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients
Simona Giglio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Prostate cancer
Richard J. Rebello et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
Joao Lobo et al.
CANCERS (2021)
Small Extracellular Vesicle-Derived microRNAs Stratify Prostate Cancer Patients According to Gleason Score, Race and Associate with Survival of African American and Caucasian Men
Hamdy E. A. Ali et al.
CANCERS (2021)
Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
MeeYoung Kim et al.
SCIENTIFIC REPORTS (2021)
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
Paolo Gandellini et al.
CANCERS (2021)
miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma
Hiresh Ayoubian et al.
CANCERS (2021)
MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia
Irena Abramovic et al.
CANCERS (2021)
MicroRNA-940 as a Potential Serum Biomarker for Prostate Cancer
Smrithi Rajendiran et al.
FRONTIERS IN ONCOLOGY (2021)
A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis
Jin Piao et al.
CLINICAL GENITOURINARY CANCER (2021)
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
Ragnhild Hellesnes et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Maria Jenvin Stoen et al.
SCIENTIFIC REPORTS (2021)
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Mette Pernille Myklebust et al.
SCIENTIFIC REPORTS (2021)
Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma
Dennis M. Timmerman et al.
CANCERS (2021)
Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer-A Multi-Institutional Study
Maria J. Stoen et al.
CANCERS (2021)
Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
Sun Shin et al.
NPJ GENOMIC MEDICINE (2021)
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
Joao Lobo et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node Dissection
John T. Lafin et al.
EUROPEAN UROLOGY OPEN SCIENCE (2021)
Penile cancer: potential target for immunotherapy?
Joren Vanthoor et al.
WORLD JOURNAL OF UROLOGY (2021)
Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome
Jouhyun Jeon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
The pre-analytical phase of the liquid biopsy
Francesca Salvianti et al.
NEW BIOTECHNOLOGY (2020)
Clinical utility of emerging biomarkers in prostate cancer liquid biopsies
Emmy Boerrigter et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma
Gazanfer Belge et al.
IN VIVO (2020)
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
A. H. Zedan et al.
SCIENTIFIC REPORTS (2020)
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study
Guillemette E. Benoist et al.
CLINICAL CHEMISTRY (2020)
Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
Gazanfer Belge et al.
Oncotarget (2020)
Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up-A Copenhagen Experience
Nina Morup et al.
CANCERS (2020)
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
Kristian Almstrup et al.
NATURE REVIEWS UROLOGY (2020)
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
Jacob Fredsoe et al.
DIAGNOSTICS (2020)
MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer
Ewa Ciszkowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer
Angelika Borkowetz et al.
DIAGNOSTICS (2020)
Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
Siri H. Strand et al.
SCIENTIFIC REPORTS (2020)
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
Anna L. Lembeck et al.
NON-CODING RNA (2020)
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations
Thomas Van den Broeck et al.
EUROPEAN UROLOGY FOCUS (2020)
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
Fumihiko Urabe et al.
CLINICAL CANCER RESEARCH (2019)
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine
Jacob Fredsoe et al.
CLINICAL CHEMISTRY (2019)
Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors
Daniel Charytonowicz et al.
CLINICAL GENITOURINARY CANCER (2019)
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine
Jacob Fredsoe et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Smarter screening for prostate cancer
Guan Hee Tan et al.
WORLD JOURNAL OF UROLOGY (2019)
Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation
W. P. A. Boellaard et al.
ANDROLOGY (2019)
Quantitative PCR Measurement o miR-371a-3p and miR-372-p Is Influenced by Hemolysis
Mette Pernille Myklebust et al.
FRONTIERS IN GENETICS (2019)
MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL
Robert K. Nam et al.
PROSTATE (2019)
Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer
E. Richardsen et al.
SCIENTIFIC REPORTS (2019)
Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration
A. Radtke et al.
ANDROLOGY (2019)
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum
Lucia Nappi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Circulating microRNAs in plasma before and after radical prostatectomy
Alicia C. McDonald et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
David Bidarra et al.
FRONTIERS IN ONCOLOGY (2019)
miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
Ximena Rosas Plaza et al.
CELLS (2019)
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection
Maurizia Mello-Grand et al.
CARCINOGENESIS (2019)
Clinical utility of plasma miR-371a-3p in germ cell tumors
Michal Mego et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
Ahmed H. Zedan et al.
PROSTATE (2019)
Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
Joao Lobo et al.
CELLS (2019)
The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies
Chun-Jiao Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer
Heather H. Cheng et al.
PROSTATE (2018)
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
L. Schmidt et al.
ANNALS OF ONCOLOGY (2018)
Diagnostic and Prognostic Value of Serum miR-15a and miR-16-1 Expression Among Egyptian Patients with Prostate Cancer
Haidy E. Zidan et al.
IUBMB LIFE (2018)
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor
Ricardo Leao et al.
JOURNAL OF UROLOGY (2018)
Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance
Richard S. C. Liu et al.
JOURNAL OF UROLOGY (2018)
Germ cell tumour subtypes display differential expression of microRNA371a-3p
Barbara Vilela-Salgueiro et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1
Arlo Radtke et al.
UROLOGIA INTERNATIONALIS (2018)
Integrated Molecular Characterization of Testicular Germ Cell Tumors
Hui Shen et al.
CELL REPORTS (2018)
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
Angelika Terbuch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
Daniela C. F. Salvatori et al.
STEM CELL REPORTS (2018)
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine
Jacob Fredsoe et al.
EUROPEAN UROLOGY FOCUS (2018)
Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma
Elektra Peta et al.
HUMAN PATHOLOGY (2017)
Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series
Petra Anheuser et al.
UROLOGIA INTERNATIONALIS (2017)
microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
Ton van Agthoven et al.
CELLULAR ONCOLOGY (2017)
Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact
Hellen Kuasne et al.
ONCOTARGET (2017)
High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
Yngve Nordby et al.
SCIENTIFIC REPORTS (2017)
Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma
Fabio Albuquerque Marchi et al.
SCIENTIFIC REPORTS (2017)
Long-term toxicity of cisplatin in germ-cell tumor survivors
M. Chovanec et al.
ANNALS OF ONCOLOGY (2017)
Relationship between human papillomavirus and penile cancer-implications for prevention and treatment
Laura C. Kidd et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
Hui-Ming Lin et al.
BRITISH JOURNAL OF CANCER (2017)
The utility of urine-circulating miRNAs for detection of prostate cancer
Kristina Stuopelyte et al.
BRITISH JOURNAL OF CANCER (2016)
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Linda Fabris et al.
EUROPEAN UROLOGY (2016)
Clarifying the PSA grey zone: The management of patients with a borderline PSA
Talisa Ross et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2016)
Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome
Juliane M. Hartz et al.
JOURNAL OF UROLOGY (2016)
miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
Song Xu et al.
MOLECULAR MEDICINE REPORTS (2016)
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
Alberto Ivan Salido-Guadarrama et al.
MOLECULAR MEDICINE REPORTS (2016)
The translational potential of microRNAs as biofluid markers of urological tumours
Annika Fendler et al.
NATURE REVIEWS UROLOGY (2016)
MiR-301a Regulates E-Cadherin Expression and Is Predictive of Prostate Cancer Recurrence
Robert K. Nam et al.
PROSTATE (2016)
MicroRNA miR-371a-3p-A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid
Klaus-Peter Dieckmann et al.
UROLOGIA INTERNATIONALIS (2016)
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
Giovanni Cochetti et al.
ONCOTARGETS AND THERAPY (2016)
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
Helle Kristensen et al.
Oncotarget (2016)
Analysis of circulating miRNAs 21 and 375 as potential biomarkers for early diagnosis of prostate cancer
Y. Gao et al.
NEOPLASMA (2016)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer
Pijun Gong et al.
RADIATION RESEARCH (2015)
MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing
Li Zhang et al.
PLOS ONE (2015)
Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling
M. A. Rijlaarsdam et al.
ANDROLOGY (2015)
MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker
M. Spiekermann et al.
ANDROLOGY (2015)
Profiling of Expression of Human Papillomavirus-Related Cancer miRNAs in Penile Squamous Cell Carcinomas
Luisa Barzon et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin et al.
BRITISH JOURNAL OF CANCER (2014)
Contralateral testicular biopsy in patients with germ cell tumors. Practice patterns in Germany 2014
K. -P. Dieckmann et al.
UROLOGE (2014)
The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
M. Avgeris et al.
BRITISH JOURNAL OF CANCER (2013)
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
L. A. Selth et al.
BRITISH JOURNAL OF CANCER (2013)
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle
Ad J. M. Gillis et al.
MOLECULAR ONCOLOGY (2013)
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
K-P Dieckmann et al.
BRITISH JOURNAL OF CANCER (2012)
Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?
Gazanfer Belge et al.
EUROPEAN UROLOGY (2012)
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
Luke A. Selth et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Regulation of cellular miRNA expression by human papillomaviruses
Zhi-Ming Zheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2011)
Serum miRNA-21: Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy
Hai-Liang Zhang et al.
PROSTATE (2011)
Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets
Roger D. Palmer et al.
CANCER RESEARCH (2010)
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
Martin Spahn et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
PM Voorhoeve et al.
CELL (2006)
Share Paper
